Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,548.17
-13.1079-0.84%
Number of Gainers:1
Number of Losers:6
Number of Flat:- -
PE:- -
High:1,569.66
Open:1,563.81
Low:1,545.55
Close:1,561.28
Volume:46.94M
Turnover:4.25B
Market Cap:1.61T
Float Cap:1.55T

Loading ...

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Pfizer Advances Alopecia Areata Drug Ritlecitinib in Key Phase 3 Trial

TIPRANKS
·
Sep 11

Novo Nordisk’s CagriSema Trial Targets Painful Diabetic Nerve Damage

TIPRANKS
·
Sep 11

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Dow Jones
·
Sep 10

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

Novo Nordisk's Semaglutide Injection Gets Chinese Approval for MASH Treatment

MT Newswires Live
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Novartis India Hits Record High After Recent Acquisition, Distribution Deal

Reuters
·
Sep 10

Amgen to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 10

TwoStep Therapeutics Raises $62.5 Million in Series a Led by Insight Partners, Medical Excellence Capital

Reuters
·
Sep 10

Novo Nordisk Advances Oral Semaglutide Trial in Obesity: What Investors Should Watch

TIPRANKS
·
Sep 10

Novo Nordisk A/S Series B Stock Falls Wednesday

Dow Jones
·
Sep 10

Novo Nordisk Advances DKK 15 Billion Share Buyback, Holding 1% of Capital in Treasury Stock

TIPRANKS
·
Sep 09

BMO Capital Adjusts Price Target on Pfizer to $35 From $30, Keeps Outperform Rating

MT Newswires Live
·
Sep 09

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 09

LIVE Markets-Europe Before the Bell: Eyeing Another Soft Open

Reuters
·
Sep 09

Amgen Shares Plunge to Decade Low After Rival Drug Trial Fails, BMO Cuts Rating

Stock News
·
Sep 09

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

TIPRANKS
·
Sep 09